Ozawade

Ozawade is owned by Bioprojet Pharma, headquartered in France. No. The ultimate owner of Ozawade, Bioprojet Pharma, is headquartered in France, not in the United States.

Bioprojet is an independent French pharmaceutical company focused on the design and development of innovative medicines, particularly in the fields of neurology and sleep disorders.

Bioprojet Deutschland GmbH